RecruitingNCT06560424
Cardiovascular and Metabolic Sciences Biorepository
Sponsor
The Cleveland Clinic
Enrollment
10,000 participants
Start Date
Sep 18, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of the Cardiovascular and Metabolic Sciences Biorepository is to collect and store information and biospecimens (blood, urine, stool, and heart tissue) from patients with and without cardiovascular and metabolic diseases to create a readily available biorepository of samples and related medical health information to expedite future research into the causes and consequences of cardiovascular and metabolic diseases.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Willing and able to sign the informed consent document
Exclusion Criteria1
- Chronic anemia (hemoglobin consistently <9 g/L)
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06560424
Related Trials
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
NCT011434543 locations
Diabetes and Heart Disease Risk in Blacks
NCT000018531 location
Hypertension Explored in Long-term Postpartum Follow-up in Later Life
NCT061870121 location
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731152 locations
SMART to Optimize an Intervention to Maintain Health Improvements After Cardiac Rehabilitation
NCT068867891 location